Home Ricerca Sedi Chi siamo Organigramma Personale Contatti Didattica Login Documenti EN
Progetti in evidenza
INCIPIT
(Link esterno)

ISTAPCA
(1007 visite)

LightDyNAmics
(509 visite)

Fondo Europeo Pesca
(407 visite)

 INMiND
(1018 visite)

Fondazione Veronesi
(Link esterno)

Instruct-IT
(Link esterno)

Euro-BioImaging
(Link esterno)

 PRIN
(1153 visite)

 eHealthNet
(945 visite)

  Ponrec
(892 visite)

MFAG Grant
(975 visite)

MERIT
(Link esterno)


Collegamenti

Ricerca:      Estesa  
Foto
NomeFrancesca Iommelli
AreaRicerca e Sviluppo
QualificaRicercatore
SedeNapoli - De Amicis
IndirizzoVia De Amicis 95, 80145 Napoli - Italia
E-mailfrancesca.iommelliibb.cnr.it
Telefono ufficio+39 081 2203430
Cellulare+39 366.611.53.32
Curriculum vuoto


Contiene: [X]      Estesa  

Autori: [X]   E Tipo di lavoro: [X]

E Data iniziale: Data finale: [X]   E Sede:  E    Affiliazione IBB   [Pulisci modulo]

Ordina per:   data    titolo    impact factor

* Inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET co-targeting efficacy in non-small cell lung cancer detected by 18F-fluorothymidine (21 visite)
Iommelli F, De Rosa V, Terlizzi C, Monti M, Panico M, Fonti R, Del Vecchio S
Clin Cancer Res, 2018; N/D: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells (53 visite)
Monti M, Iommelli F, De Rosa V, Carriero MV, Miceli R, Camerlingo R, Di Minno G, Del Vecchio S
Plosone, 2017 Feb; N/D: 1-15.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors (63 visite)
De Rosa V, Iommelli F, Monti M, Mainolfi CG, Fonti R, Del Vecchio S
Ejnmmi Res, 2016 Dec; 6(1): 74-74.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Preclinical imaging in oncology: advances and perspectives (57 visite)
Iommelli F, De Rosa V, Terlizzi C, Del Vecchio S
Q J Nucl Med Mol Imaging (ISSN: 1827-1936electronic, 1824-4785linking), 2016 Nov 18; 61(1): 33-47.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer (259 visite)
De Rosa V, Iommelli F, Monti M, Fonti R, Votta G, Stoppelli MP, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432linking, 1078-0432electronic), 2015 Nov 15; 21(22): 5110-5120.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FLT PET/CTas a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC (66 visite)
Iommelli F, De Rosa V, Monti M, Panico M, Fonti R, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2015 Oct; 42: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Changes of glycolytic pathway and upregulation of oxidative phosphorylation in BCR-ABL-driven human leukemia cells treated with imatinib (96 visite)
Monti M, De Rosa V, Iommelli F, Fonti R, Pane F, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2015 Oct; 42: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC (148 visite)
De Rosa V, Iommelli F, Monti M, Mainolfi C, Fonti R, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2015 Oct; 42: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Early reduction of 18F-FDG uptake in non-small lung cancer treated with EGFR tyrosine kinase inhibitors reflects reversal of Warburg effect and reactivation of oxidative phosphorylation (71 visite)
De Rosa V, Iommelli F, Monti M, Fonti R, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2014 Oct; 41: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Monitoring Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by 18F-FLT PET/CT (67 visite)
Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Gramanzini M, Fonti R, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2014 Oct; 41: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Using 3 '-Deoxy-3 '-[F-18]-Fluorothymidine Positron Emission Tomography (142 visite)
Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Greco A, Gramanzini M, Ortosecco G, Fonti R, Brunetti A, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking), 2014 Sep 15; 20(18): 4806-4815.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Molecular Imaging For Detection Of Sensitivity And Resistance To Egfr Tyrosine Kinase Inhibitors In Non-Small Cell Lung Cancer (82 visite)
Iommelli F, De Rosa V, Fonti R, Del Vecchio S
Clinical And Translational Imaging (ISSN: 2281-5872print, 2281-7565online), 2014 Feb 20; 2(1): 43-53.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models (102 visite)
Formisano L, Nappi L, Rosa R, Marciano R, D'Amato C, D'Amato V, Damiano V, Raimondo L, Iommelli F, Scorziello A, Troncone G, Veneziani BM, Parsons SJ, De Placido S, Bianco R
Breast Cancer Res Biomed Central Ltd (ISSN: 1465-5411), 2014; 16(3): R45-R45.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FLT PET/CT for Detection of Functional Cross-talk between MET and EGFR in Non-small Cell Lung Cancer Resistant to EGFR Inhibitors (68 visite)
Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Ortosecco G, Greco A, Gramanzini M, Fonti R, Brunetti A, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Changes of Glycolytic Pathway in Response to Efficient Inhibition of EGFR Signaling in Non-small Cell Lung Cancer (NSCLC) (60 visite)
De Rosa V, Iommelli F, Votta G, Monti M, Ortosecco G, Fonti R, Mainolfi C, Stoppelli M, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer (73 visite)
Zannetti A, Iommelli F, De Rosa V, Nardelli A, Ortosecco G, Del Vecchio S
European Journal Of Cancer (ISSN: 0959-8049), 2012 Nov; 48: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors (75 visite)
Zannetti A, Iommelli F, De Rosa V, Salvatore M, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 3'-deoxy-3'-18F-fluorothymidine (FLT) PET/CT to guide therapy with epidermal growth factor receptor (EGFR) antagonists and Bcl-xL inhibitors in non-small cell lung cancer (184 visite)
Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S
Journal Of Nuclear Medicine (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer (120 visite)
Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S
Journal Of Nuclear Medicine (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Stato Dell’arte Dell’imaging Preclinico In Oncologia (69 visite)
Del Vecchio S, Zannetti A, Iommelli F, Fonti R, Speranza A
Quarterly Journal Of Nuclear Medicine And Molecular Imaging (ISSN: 1827-1936), 2011; 55: 20-21.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* PET/CT in cancer research: From preclinical to clinical applications (110 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Pizzuti LM, Lettieri A, Salvatore M
Contrast Media Mol Imaging (ISSN: 1555-4309), 2010 Jul; 5(4): 190-200.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Molecular imaging of tumor microenvironment (72 visite)
Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 243-258.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Molecular imaging of tumor microenvironment: Challenges and perspectives (128 visite)
Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 249-258.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5) (80 visite)
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A,  De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking), 2009 Sep 15; 15(16): 5224-5233.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with α vβ5 (89 visite)
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking), 2009 Sep 15; 15(16): 5224-5233.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of Bcl-2/Bcl-x(L) dysregulated apoptotic program in NSCLC cells resistant to EGFR tyrosine kinase inhibitors (64 visite)
Zannetti A, Iommelli F, Fonti R, Lettieri A, Pirozzi G, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* MicroPET/CT of mice bearing alpha(v)beta(3)-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide (88 visite)
Zannetti A, Iommelli F, Panico M, Del Gatto A, Zaccaro L, Saviano M, Pedone C, Salvatore M, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Molecular imaging of drug resistance in cancer (68 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Lettieri A, Salvatore M
Minerva Biotecnol (ISSN: 1120-4826), 2009 Mar; 21(1): 31-36.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of lung cancer resistance to EGFR tyrosine kinase inhibitors through Bcl-2/Bcl-x(L) modulation of inositol trisphosphate receptor type (65 visite)
Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type (131 visite)
Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Pirozzi G, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking), 2008 Sep 15; 14(16): 5209-5219.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging Of Lung Cancer Resistance To Egfr Tyrosine Kinase Inhibitors Trough Bcl-2/Bcl-Xl Modulation Of Inositol Trisphosphate Receptor Type (66 visite)
Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Eur J Nucl Med, 2008; suppl2: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* In vivo imaging of alpha(v) beta(3) integrin expression with a radiolabeled chimeric RGD peptide (74 visite)
Del Vecchio S, Zannetti A, Panico M, Speranza A, Iommelli F, Papaccioli A, Sommella J, Lettieri A, Saviano M, Zaccaro L, Del Gatto A, Lang L, Pedone C, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* SPECT imaging of endoplasmic reticulum-mediated tumor response to gefitinib and erlotinib in lung cancer (93 visite)
Zannetti A, Fonti R, Iommelli F, Papaccioli A, Sommella J, Tortora G, Bianco R, Salvatore M, Del Vecchio S
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: 277-309.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* In vivo detection of early tumor response to tyrosine kinase inhibitors by microSPECT with 99mTc-MIBI (69 visite)
Del Vecchio S, Zannetti A, Iommelli F, Papaccioli A, Sommella J, Ferraro P, Baiano A, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Novel And Selective Alpha (v) Beta3 Receptor Peptide Antagonist: Design, Synthesis, And Biological Behavior (130 visite)
Del Gatto A, Zaccaro L, Grieco P, Novellino E, Zannetti A, Del Vecchio S, Iommelli F, Salvatore M, Pedone C, Saviano M
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2006 Jun 1; 49(11): 3416-3420.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Inhibition of NF-kappa B activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells (61 visite)
Iommelli F, Zannetti A, Pepe S, Sabbatino F, Laus G, Ghidelli L, Solla R, Scala S, Del Vecchio S, Salvatore M, Pacelli R
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 2006 Apr; 47: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells during treatment with gefitinib, a selective tyrosine kinase inhibitor (65 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Sommella I, Potena A, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Characterization of a novel RGD-containing peptide with improved selectivity for imaging alpha v beta 3 integrin expression (80 visite)
Del Vecchio S, Zannetti A, Del Gatto A, Grieco P, Iommelli F, Zaccaro L, Panico M, Saviano M, Blystone SD, Pedone C, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Gefitinib, A Selective, Tyrosine Kinase Inhibitor Increases 99mtc-Mibi Uptake In Bcl-2 Overexpressing Breast Cancer Cells (61 visite)
Zannetti A, Del Vecchio S, Fonti R, Iommelli F, Sommella J, Potena A, Salvatore M
Mol Immunol, 2005; 4: 355-355.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake in Bcl-2 overexpressing non-Hodgkin's lymphoma patients during drug-induced apoptosis (62 visite)
Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Iommelli F, De Renzo A, Rotoli B, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Sep; 31: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Tc-99m-MIBI in the evaluation of breast cancer biology (200 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Salvatore M
Breast Cancer (ISSN: 9783-540367802), 2004 Jun; 1: 71-81.
Dettagli    Esporta in BibTeX    Esporta in EndNote



41 Records (20 escludendo Abstract e Conferenze).
Impact factor totale: 176.858 (86.234 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 173.267 (82.479 escludendo Abstract e Conferenze).

Interrogazione bibliografica effettuata: ([author] IOMMELLI_F)








Ultima modifica di Francesca Iommelli in data Tuesday 17 April 2018, 15:57:00
1380 visite. Ultima visita in data Wednesday 23 May 2018, 13:03:54

Webmaster and developer: Marco Comerci
Per problemi e suggerimenti: adminibb.cnr.it
Ultimo aggiornamento: Thursday 24 May 2018, 14:37:17